# DeepSynaps Clinical Intelligence OS > Clinical software for mental health and neuromodulation clinics: clinician-reviewed qEEG reports, protocol templates, patient workflow and evidence maps. Availability: Phase 1 focuses on qEEG reports and approved Neuromodulation Studio templates, supported by patient management, scheduling, inbox and evidence workflows. The wider analyzer, Twin and Studio catalog shows the platform direction; access varies by capability. Clinical responsibility: The platform supports qualified professionals with review and workflow tools. It does not provide medical advice or replace independent clinical judgement. Clinicians remain responsible for clinical decisions, including neuromodulation planning and report release. ## Product - [DeepSynaps Clinical Intelligence OS](https://app.deepsynaps.com/): home page and access requests - [qEEG Analyzer](https://app.deepsynaps.com/qeeg-analyzer/): qEEG decision-support workstation — band power, asymmetry, coherence, topographic maps, spectral markers, and longitudinal trends. Clinician review required. - [Neuromodulation Studio](https://app.deepsynaps.com/neuromodulation-studio/): Plan TMS, tDCS, tACS and neurofeedback workflows with evidence, safety checks and clinician sign-off. - [Questions](https://app.deepsynaps.com/faq/): the landing FAQ as a page ## Evidence maps Research-landscape pages for neuromodulation treatments, one per treatment and condition (snapshot 2026-09-25). Hub: https://app.deepsynaps.com/evidence/ ### Movement disorders - [DBS for Parkinson’s disease](https://app.deepsynaps.com/evidence/dbs-parkinsons-disease/): 9,164 papers - [DBS for essential tremor](https://app.deepsynaps.com/evidence/dbs-essential-tremor/): 1,415 papers - [MRgFUS for essential tremor](https://app.deepsynaps.com/evidence/focused-ultrasound-essential-tremor/): 271 papers ### Depression - [rTMS for major depressive disorder](https://app.deepsynaps.com/evidence/rtms-depression/): 3,320 papers - [tDCS for depression](https://app.deepsynaps.com/evidence/tdcs-depression/): 1,232 papers - [VNS for treatment-resistant depression](https://app.deepsynaps.com/evidence/vns-depression/): 1,043 papers - [PBM for major depressive disorder](https://app.deepsynaps.com/evidence/photobiomodulation-depression/): 129 papers ### Epilepsy - [VNS for refractory epilepsy](https://app.deepsynaps.com/evidence/vns-epilepsy/): 2,111 papers - [DBS for refractory focal epilepsy](https://app.deepsynaps.com/evidence/dbs-epilepsy/): 1,457 papers - [RNS for focal epilepsy](https://app.deepsynaps.com/evidence/responsive-neurostimulation-epilepsy/): 653 papers - [Neurofeedback for drug-resistant epilepsy](https://app.deepsynaps.com/evidence/neurofeedback-epilepsy/): 137 papers ### Bladder and bowel - [SNM for bladder and bowel dysfunction](https://app.deepsynaps.com/evidence/sacral-neuromodulation-bladder-bowel/): 1,883 papers ### OCD - [DBS for treatment-refractory OCD](https://app.deepsynaps.com/evidence/dbs-ocd/): 1,171 papers - [Deep TMS for OCD](https://app.deepsynaps.com/evidence/deep-tms-ocd/): 491 papers ### Chronic pain - [SCS for failed back surgery syndrome](https://app.deepsynaps.com/evidence/spinal-cord-stimulation-back-pain/): 517 papers - [DRG for CRPS and focal neuropathic pain](https://app.deepsynaps.com/evidence/drg-stimulation-crps/): 352 papers - [SCS for painful diabetic neuropathy](https://app.deepsynaps.com/evidence/spinal-cord-stimulation-diabetic-neuropathy/): 291 papers ### Sleep apnea - [HNS for obstructive sleep apnea](https://app.deepsynaps.com/evidence/hypoglossal-nerve-stimulation-sleep-apnea/): 424 papers - [PNS for central sleep apnea](https://app.deepsynaps.com/evidence/phrenic-nerve-stimulation-central-sleep-apnea/): 119 papers ### ADHD, anxiety and PTSD - [Neurofeedback for ADHD](https://app.deepsynaps.com/evidence/neurofeedback-adhd/): 376 papers - [Neurofeedback for anxiety and PTSD](https://app.deepsynaps.com/evidence/neurofeedback-anxiety-ptsd/): 250 papers ### Rehabilitation - [VNS for post-stroke arm rehabilitation](https://app.deepsynaps.com/evidence/vns-stroke-rehabilitation/): 322 papers ### Heart failure - [BAT for heart failure](https://app.deepsynaps.com/evidence/baroreflex-activation-heart-failure/): 163 papers ### Migraine and headache - [nVNS for migraine and cluster headache](https://app.deepsynaps.com/evidence/nvns-migraine-cluster-headache/): 117 papers - [REN for migraine](https://app.deepsynaps.com/evidence/remote-electrical-neuromodulation-migraine/): 74 papers - [e-TNS for migraine](https://app.deepsynaps.com/evidence/trigeminal-nerve-stimulation-migraine/): 65 papers ### Alzheimer’s disease and cognition - [PBM for Alzheimer’s disease and MCI](https://app.deepsynaps.com/evidence/photobiomodulation-alzheimers/): 77 papers - [TPS for Alzheimer’s disease](https://app.deepsynaps.com/evidence/transcranial-pulse-stimulation-alzheimers/): 59 papers ## Articles Research overviews built from the evidence maps. Index: https://app.deepsynaps.com/blog/ - [Neuromodulation research in numbers: 28 treatments and conditions compared](https://app.deepsynaps.com/blog/neuromodulation-research-in-numbers/): How much research exists for DBS, VNS, rTMS, tDCS, spinal cord stimulation, neurofeedback and more: papers, trials and reviews side by side. - [Brain stimulation for depression: the research on rTMS, tDCS, VNS and PBM compared](https://app.deepsynaps.com/blog/brain-stimulation-for-depression-research/): Papers, randomised trials, reviews and growth for four neuromodulation approaches to depression, with the most-cited trial for each and links to the sources. ## Questions - **Who is the clinical beta for?** Clinicians, qEEG and neuromodulation teams, clinic owners and researchers working in mental health and neuromodulation. Developers and integration partners can also apply. Access is reviewed by the DeepSynaps team. - **What can my team explore first?** Phase 1 focuses on qEEG reports and approved Neuromodulation Studio templates, supported by patient management, scheduling, inbox and evidence workflows. The wider analyzer, Twin and Studio catalog shows the platform direction; access varies by capability. - **What happens after I apply?** The DeepSynaps team reviews your role, organisation and workflow, then follows up about fit and available access. Applications open access in small cohorts. Applying does not automatically create a professional account. - **Is every NERVE available now?** Mental Health & Neuromodulation is the current focus. Grey specialty NERVEs show future directions. The neural map explains how data, analyzers, Twins and workspaces connect; it is an interactive product illustration, not a live model of a patient’s brain. - **Can the platform make clinical decisions for me?** The platform supports qualified professionals with review and workflow tools. It does not provide medical advice or replace independent clinical judgement. Clinicians remain responsible for clinical decisions, including neuromodulation planning and report release. - **Should I include patient information in my application?** No. Use the application only to describe your professional role and organisation. Do not enter patient-identifiable information on this public page. Clinical data access is handled separately through the appropriate organisation, consent and access arrangements. - **Do I need payment details to apply?** No payment details are needed to apply. Beta availability, scope and any applicable commercial terms are confirmed with your team during the review process. ## Other DeepSynaps sites - [DeepSynaps AI Lab](https://deepsynaps.ai/): Developing AWIM, the Adaptive World Intelligence Model. - [DeepSynaps Lab](https://deepsynapslab.com/): Research division building neuromorphic photonic AI chips (HAC v1 and HAC v2). - [DeepSynaps Academy](https://deepsynapsacademy.com/): Seminars, workshops, online courses and consultations on neuromodulation, neuroscience and clinical AI. - [DeepSynaps Türkiye](https://deepsynapsturkiye.com/): Brain mapping, clear reports and personalised follow-up in Türkiye (site in Turkish). ## Optional - [Full public content](https://app.deepsynaps.com/llms-full.txt): every product page, the FAQ, the articles and each evidence map in one file ## Contact and policies - Contact: ali.yildirim@deepsynaps.com - [Privacy Policy](https://app.deepsynaps.com/privacy/) - [Terms of Service](https://app.deepsynaps.com/terms/)